Cymat Technologies Stock Today
CYMHF Stock | USD 0.13 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 21
|
Cymat Technologies is trading at 0.13 as of the 6th of May 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.13. Cymat Technologies has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Cymat Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of April 2024 and ending today, the 6th of May 2024. Click here to learn more.
Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company was incorporated in 2006 and is based in Mississauga, Canada. Cymat Technologies is traded on OTC Exchange in the United States. The company has 59.09 M outstanding shares. More on Cymat Technologies
Moving against Cymat OTC Stock
0.75 | CHKEZ | Chesapeake Energy | PairCorr |
0.73 | KNTK | Kinetik Holdings | PairCorr |
0.71 | MRLWF | Marlowe plc | PairCorr |
0.7 | CHKEL | Chesapeake Energy | PairCorr |
0.62 | PCGU | PGE Corp | PairCorr |
0.6 | PCTTW | PureCycle Technologies | PairCorr |
0.59 | GOOD | Gladstone Commercial | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Cymat OTC Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cymat Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cymat Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business Concentration | Materials, Metals & Mining, Metal Fabrication, Industrials (View all Sectors) |
Cymat Technologies [CYMHF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cymat Technologies's market, we take the total number of its shares issued and multiply it by Cymat Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cymat Technologies classifies itself under Metals & Mining sector and is part of Materials industry. The entity has 59.09 M outstanding shares.
Cymat Technologies has accumulated about 2.21 M in cash with (4.32 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Cymat Technologies Probability Of Bankruptcy
Ownership AllocationCymat Technologies holds a total of 59.09 Million outstanding shares. Cymat Technologies shows 6.28 percent of its outstanding shares held by insiders and 2.38 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cymat Ownership Details
Cymat Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Cymat Technologies jumping above the current price in 90 days from now is about 83.42%. The Cymat Technologies probability density function shows the probability of Cymat Technologies otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Cymat Technologies has a beta of 0.5283 suggesting as returns on the market go up, Cymat Technologies average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cymat Technologies will be expected to be much smaller as well. Additionally, cymat Technologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Cymat Technologies to move above the current price in 90 days from now is about 83.42 (This Cymat Technologies probability density function shows the probability of Cymat OTC Stock to fall within a particular range of prices over 90 days) .
Cymat Technologies Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cymat Technologies market risk premium is the additional return an investor will receive from holding Cymat Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cymat Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cymat Technologies' alpha and beta are two of the key measurements used to evaluate Cymat Technologies' performance over the market, the standard measures of volatility play an important role as well.
Mean Deviation | 1.7 | |||
Standard Deviation | 3.92 | |||
Variance | 15.37 | |||
Risk Adjusted Performance | 0.0025 |
Cymat Stock Against Markets
Picking the right benchmark for Cymat Technologies otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cymat Technologies otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cymat Technologies is critical whether you are bullish or bearish towards Cymat Technologies at a given time. Please also check how Cymat Technologies' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cymat Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
All Next | Launch Module |
Cymat Technologies Corporate Management
Elected by the shareholders, the Cymat Technologies' board of directors comprises two types of representatives: Cymat Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cymat. The board's role is to monitor Cymat Technologies' management team and ensure that shareholders' interests are well served. Cymat Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cymat Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
Jim Johnson | VP of Operations | Profile | |
Darryl Kleebaum | Chief Officer | Profile | |
Mario DeAngelis | Chief Officer | Profile | |
Vince Benincasa | Chief Officer | Profile | |
David Henry | Head Devel | Profile | |
P MBA | Ex CEO | Profile |
How to buy Cymat OTC Stock?
Before investing in Cymat Technologies, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Cymat Technologies. To buy Cymat Technologies stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Cymat Technologies. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Cymat Technologies stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Cymat Technologies stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Cymat Technologies stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Cymat Technologies, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Cymat Technologies?
The danger of trading Cymat Technologies is mainly related to its market volatility and OTC Stock specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cymat Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cymat Technologies. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cymat Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cymat Technologies. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Cymat Technologies information on this page should be used as a complementary analysis to other Cymat Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Cymat OTC Stock analysis
When running Cymat Technologies' price analysis, check to measure Cymat Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cymat Technologies is operating at the current time. Most of Cymat Technologies' value examination focuses on studying past and present price action to predict the probability of Cymat Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cymat Technologies' price. Additionally, you may evaluate how the addition of Cymat Technologies to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |